Senseonics Holdings, Inc.
SENS Healthcare Medical Devices
Senseonics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.3 million, up 56.9% from fiscal 2024. In the quarter to June 2026, revenue grew 117.8%, EPS fell 57.5%, free cash flow fell 223.2% and total debt rose 58.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow SENS
Senseonics Holdings, Inc. (SENS) EV/Sales
As of 16 October 2026, Senseonics Holdings, Inc. (SENS) trades at a EV/Sales of 8.1×. Over the past ten years it has ranged from 0.0× (June 2016) to 6,244× (August 2016); the current reading is higher than 14% of that period. That is above the Medical Devices industry median of 2.2× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 5.7× | (59.88%) |
| FY2024 | 14.1× | 13.74% |
| FY2023 | 12.4× | (51.85%) |
| FY2022 | 25.8× | (66.76%) |
| FY2021 | 77.5× | 59.27% |
| FY2020 | 48.7× | 438.61% |
| FY2019 | 9.0× | (49.56%) |
| FY2018 | 17.9× | (60.77%) |
| FY2017 | 45.7× | (93.64%) |
| FY2016 | 718× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 5.6× | (25.80%) |
| Mar 2026 | 7.5× | 32.10% |
| Dec 2025 | 5.7× | (51.78%) |
| Sep 2025 | 11.7× | (7.62%) |
| 40 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OFIX ORTHOFIX MEDICAL INC. compare | 0.6× |
| VMD Viemed Healthcare, Inc. compare | 1.2× |
| CERS Cerus Corporation compare | 1.8× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 2.6× |
| NPCE NeuroPace, Inc. compare | 4.2× |
| SI Shoulder Innovations, Inc. compare | 4.8× |
| SGHT Sight Sciences, Inc. compare | 4.9× |
| MASS 908 Devices Inc. compare | 5.6× |
| SENS Senseonics Holdings, Inc. | 8.1× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)